Rebalix
Logo AmundiAmundi · sheet of 5 September 2026
ETF sheet · official issuer and register data

Amundi PEA S&P 500 UCITS ETF Acc

PSP5 · FR0011871128 · class UCITS ETF Acc · EUR · domicile France
Equity · United States · Large capSFDR art. 6
Index tracked: S&P 500 Net Total Return Index
TER
0.12%+ trans. 0.00%
Fund size
1.2 bn EUR
Tracking difference
+0.07%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 20 May 2014 · costs from the KID as of 2 Sept 2026 · 79 securities held · 6 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · unofficial translation, the original prevails · 7 Aug 2026
The fund is a passively managed index-tracking UCITS. The investment objective is to replicate, both upward and downward, the evolution of the S&P 500 Net Total Return Index (net dividends reinvested) (the "Benchmark Index"), denominated in US Dollars (USD) and representative of the performance of the 500 large capitalisation stocks traded in the United States, while minimising the tracking error between the performance of the FCP and that of its Benchmark Index. The anticipated level of tracking error under normal market conditions is indicated in the…

Performance since series start (in euro) — base 100

20 May 20143 Sept 2026 · dividends reinvested where declared by the issuer
201520172019202120232025593100586
High 593 (13 Aug 2026) · low 100 (20 May 2014) · last 586. Past performance is not indicative of future results.

Returns in euro

1 year+22.1%
3 years+64.0%
5 years+84.0%
10 years+293.5%
Since series start+485.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.72%15.80%17.37%
Max drawdown−7.49%−22.42%−22.42%
Sharpe1.440.930.66
Sortino2.061.320.93
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PSP5 · FR00118711281
RebalixPSP5 · FR0011871128 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+3.45%+3.54%−0.09%
2024+32.85%+32.82%+0.03%
2023+21.68%+21.41%+0.27%
2022−13.00%−13.17%+0.17%
2021+38.23%+37.89%+0.34%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 79 securities · top-10 weight = 45.0%
Top holdingsWeight
RWE AG8.1%
BAYER AG-REG4.8%
AIRBUS SE PARIS4.5%
DEUTSCHE BANK AG NAMEN4.3%
ING GROEP NV4.1%
DEUTSCHE TELEKOM NAMEN (XETRA)4.0%
FERRARI NV MILAN3.9%
DHL GROUP (XETRA)3.9%
ACCENTURE PLC -A3.7%
MEDTRONIC PLC3.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
L8IP · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse Stuttgart, Tradegate Exchange
PSP5 · Euronext Paris
+ 20 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0011871128/FRA/FRA
Factsheet · www.amundietf.ch/pdfDocuments/monthly-factsheet/FR0011871128/ENG/CHE/R
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0011871128/FRA/FRA
The live sheet, always up to date
rebalix.com/en/etf/FR0011871128
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PSP5 · FR00118711282